Expression profiling reveals specific gene expression signatures in gastric MALT lymphomas

Area of Science:

• Oncology
• Gastroenterology
• Immunology

Background:

• Helicobacter pylori infection is a known risk factor for gastric cancers.
• Gastric Mucosa-Associated Lymphoid Tissue (MALT) lymphoma is a B-cell lymphoma arising in the stomach.
• Understanding the genetic underpinnings of H. pylori-induced gastric MALT lymphoma is crucial for diagnosis and treatment.

Purpose of the Study:

• To identify genes involved in the etiology of Helicobacter pylori-induced gastric MALT lymphoma.
• To compare gene expression profiles between gastric MALT lymphoma and chronic gastritis with lymphoid aggregates.
• To differentiate gastric MALT lymphoma from H. pylori-induced lymphoid gastritis based on gene expression.

Main Methods:

• cDNA microarrays were used to analyze gene expression in 21 patient samples comparing gastric MALT lymphoma and corresponding gastric MALT.
• Quantitative PCR and immunohistochemical staining were employed for validation.
• Statistical analysis, including EASE score, was used to identify differentially expressed genes and over-represented chromosomes.

Main Results:

• 358 out of 11,552 genes were differentially expressed between gastric MALT lymphoma and gastric MALT.
• Genes implicated in immune response (38), signal transduction (66), and cell proliferation (36) were identified.
• Chromosome 6 was significantly over-represented with 25 differentially expressed genes (EASE score p = 0.01254).
• Upregulation of hematopoietic cell surface markers (e.g., CD40, CD86, HLA-D family) suggests antigen-dependent survival of lymphoma cells.

Conclusions:

• Gastric MALT lymphoma exhibits a distinct gene expression profile compared to H. pylori-induced lymphoid gastritis.
• These findings provide molecular insights into the pathogenesis of gastric MALT lymphoma.
• The identified gene expression signature can aid in differentiating between gastric MALT lymphoma and reactive lymphoid hyperplasia.